Revelation Biosciences Inc (REVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 1,943 | 2,461 | 2,095 | 1,754 | 1,797 |
| Operating Income | -1,943 | -2,461 | -2,095 | -1,754 | -1,797 |
| Other Income | 36 | 17 | 44 | 28 | -445 |
| Pre-tax Income | -1,907 | -2,444 | -2,051 | -1,726 | -2,242 |
| Net Income Continuous | -1,907 | -2,444 | -2,051 | -1,726 | -2,242 |
| Net Income | $-1,907 | $-2,444 | $-2,051 | $-1,726 | $-2,242 |
| EPS Basic Total Ops | -7.08 | -28.04 | -25.32 | 565.90 | -160.60 |
| EPS Basic Continuous Ops | -2.88 | -12.18 | -25.35 | 568.19 | -160.11 |
| EPS Diluted Total Ops | -7.08 | -28.04 | -25.32 | 565.90 | -160.60 |
| EPS Diluted Continuous Ops | -2.88 | -12.18 | -25.35 | 568.19 | -160.11 |
| EPS Diluted Before Non-Recurring Items | -7.08 | -28.04 | -25.32 | -59.77 | -161.30 |
| EBITDA(a) | $-1,936 | $-2,454 | $-2,088 | $-1,747 | $-1,790 |